Ohio Public Employees Retirement System (OPERS)’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-32,498
Closed -$33.8K 2366
2024
Q3
$33.8K Hold
32,498
﹤0.01% 1893
2024
Q2
$56.2K Buy
+32,498
New +$65.4K ﹤0.01% 1533
2024
Q1
Sell
-4,000
Closed -$13.3K 1982
2023
Q4
$13.3K Sell
4,000
-21,642
-84% -$58K ﹤0.01% 1912
2023
Q3
$96K Buy
+25,642
New +$118K ﹤0.01% 1438
2020
Q1
Sell
-11,600
Closed -$209K 1890
2019
Q4
$209K Hold
11,600
﹤0.01% 1384
2019
Q3
$235K Buy
11,600
+8,200
+241% +$164K ﹤0.01% 1478
2019
Q2
$75K Buy
+3,400
New +$59K ﹤0.01% 1704

Other funds holding CHRS

Ohio Public Employees Retirement System (OPERS)'s CHRS Position: Q4 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Coherus Oncology (CHRS) in Q4 2024, closing a stake of 32,498 shares — an estimated $33.8K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CHRS in Q2 2019 and held it in 7 quarters. The position peaked at $235K in Q3 2019. 124 funds tracked by Wall St. Rank hold CHRS as of Q4 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Coherus Oncology position as of Q4 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 32,498 Coherus Oncology shares in Q4 2024, an estimated $33.8K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Coherus Oncology in Q2 2019 and held it in 7 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Coherus Oncology position peaked at $235K in Q3 2019.
  • 124 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2024, filed 19 Feb 2025.